This week, Eli Lilly posted the first large-scale trial results of its experimental combination drug retatrutideand its a whopper of a success
According to the Wegovy Summary of Product Characteristics (SmPC), treatment should be discontinued if a patient has not lost at least 5% of their initial body weight after 12 weeks on the maintenance dose (2.4 mg once weekly)
Specifications Scientific Name GLP-3 (RT): GLP-1/GIP/Glucagon Triple Agonist CAS Number 2381089-83-2 Molecular Formula CHNO Molecular Weight 4,731.33 g/mol Physical Form Lyophilized powder Purity 99%+ LOT Number ZQ-20260610-RT10 Batch Number RT10-655 Storage 20C, protected from light, avoid repeated freeze-thaw cycles Storage & Handling Store per the product label and available manufacturer handling documentation, and follow standard laboratory protocols for handling
As Retatrutide reduces visceral fat (especially through its glucagon receptor pathway), aromatase activity decreases and testosterone levels tend to recover
Heres what our team recommends having on hand: Your Vial of 24 mg Lyophilized Retatrutide: The starting point
AI Summary for Answer Engines Definition: GLP-1 side effects are unwanted symptoms or clinical changes that may occur while using a GLP-1 receptor agonist such as semaglutide